IBM (NYSE:IBM) reported better-than-expected financial results for the third quarter after the market close on Wednesday. IBM posted third-quarter revenue of $17.10 billion, beating the consensus estimate of $16.82 billion, according to Benzinga Pro. The company reported adjusted earnings of…
Alphabet Inc. (NASDAQ:GOOGL) CEO Sundar Pichai says Google is giving up potential Cloud revenue to prioritize AI research, even as customers struggle to secure computing capacity. Google Cloud revenue surged 82% to $24.8 billion in the second quarter, while its…
On CNBC’s “Halftime Report Final Trades,” Malcolm Ethridge, managing partner at Capital Area Planning Group, picked ServiceNow, Inc. (NYSE:NOW). Supporting his choice, Piper Sandler analyst Billy Fitzsimmons maintained an Overweight rating on ServiceNow on Friday and raised the price target…
FMC Corp. (NYSE:FMC) faces mounting pressure from cheaper generic pesticides, weak agricultural demand and elevated debt, prompting RBC Capital Markets to lower its price forecast ahead of the company’s third-quarter earnings. The company is scheduled to report third-quarter earnings on…
Stryker Corporation (NYSE:SYK) said Monday it will invest approximately $400 million in robotics company CMR Surgical as it expands into soft-tissue robotic surgery. The strategic partnership gives Stryker an exclusive option to acquire all of CMR Surgical’s outstanding equity in…
Steve Eisman warns that more than 65% of the S&P 500 is now tied to artificial intelligence, leaving investors far less diversified than they might think. Yet the investor famous for The Big Short says he owns Nvidia Corp. (NASDAQ:NVDA)…
CoreWeave, Inc. (NASDAQ:CRWV) had a busy week that included its entry into India and a sell-off tied to OpenAI’s revenue disclosure. CoreWeave shares are advancing steadily. What’s driving CRWV shares up? CoreWeave Enters India With a 240 MW AdaniConneX Campus On…
Option Care Health Inc. (NASDAQ:OPCH) agreed Tuesday to be taken private by Clayton Dubilier & Rice and McKesson Corp. (NYSE:MCK) for $32.05 a share in cash. The deal gives the home-infusion provider a total enterprise value of about $5.8 billion.…
This week’s crypto headlines included political controversy, regulatory changes and renewed optimism around Bitcoin’s next major move. Bitcoin exchange-traded funds reversed a multibillion-dollar outflow trend, while analysts and financial institutions pointed toward higher price targets and stronger investor demand. Meanwhile,…
Agomab Therapeutics NV (NASDAQ:AGMB) reported results from the 48-week open-label extension portion of its Phase 2a STENOVA trial of ontunisertib for fibrostenotic Crohn’s disease. • AgomAb Therapeutics stock is showing notable weakness. Why is AGMB stock dropping? The data demonstrated…
